Sign in
Taking peopleNo phase

Spinal cord stimulation for bladder and bowel problems after spinal cord injury

Tests spinal stimulation for bladder and bowel after spine injury.

Key facts

Who runs it
University College, London
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury
Status
Recruiting
People taking part
20 people, planned
Started
14 Oct 2024
Expected to end
1 Nov 2027
Type of study
Interventional
Treatments tested
  • Epidural Spinal Cord Stimulation
Record updated
14 March 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for up to 20 adults with a long-standing spinal cord injury above the sacral level and an overactive bladder caused by the injury. They will have a spinal cord stimulator implanted and use it at home for 12-weeks.

Age
Over 18 years.
Sex
All sexes can join.
Disease stage
Spinal cord injury above the sacral level, AIS grade A-D, sustained more than 12 months ago. Bladder and bowel routine must already be well set up. Medical, physical and psychological condition must be stable.
Earlier treatment
No botulinum toxin injections into the bladder muscle within the last 6 months. No past surgery on the bladder sphincters.
Biomarker or test result
Neurogenic detrusor overactivity (overactive bladder from nerve damage) confirmed on urodynamics (bladder function tests). Must respond to dorsal genital nerve stimulation.

Main reasons for not taking part

  • Fully cut spinal cord, or injury linked to a neurodegenerative disease
  • Devices or metal in the body, or conditions such as degenerative spine disease, syrinx or tumor, that rule out the implant or surgery
  • Repeated urinary tract infections that do not respond to antibiotics
  • Pregnant, planning pregnancy, breastfeeding, or no safe contraception
  • Use of an investigational drug in another study within the 30 days before or during this study

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Spinal Cord Injury (supra-sacral)
  • AIS A-D
  • >18 years
  • SCI sustained >12 months ago
  • Neurogenic detrusor overactivity (NDO) confirmed on urodynamics
  • Responsive to dorsal genital nerve stimulation
  • Willing and able to provide informed consent
  • Stable medical, physical and psychological condition as considered by the investigators
  • Able to understand and interact with the study team in English
  • Sufficient upper limb function to operate the device
  • Suitably optimised bladder and bowel routine

Who cannot take part

  • Previous surgical intervention on bladder sphincters
  • Participation in another study with investigational drug within the 30 days preceding and during the present study
  • Transected cord or SCI related to a neurodegenerative disease
  • Any diseases and conditions that would exclude the patient from eSCS and/or surgery, for example, degenerative spinal pathology, syrinx and/or tumor
  • Recurrent urinary tract infection refractory to antibiotics
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders or dementia of the participant
  • Any device or metal work in situ that would exclude the patient from having eSCS implanted
  • Intra-detrusor botulinum toxin injections within the last 6 months
  • Women who are pregnant or intending to become pregnant (pregnancy test obligatory for woman of childbearing potential) or breast feeding, or lack of safe contraception for women of childbearing capacity
  • Enrolment of the investigator, his/her family members, employees, and other dependent persons

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The investigators will recruit up to 20 volunteers with chronic, supra-sacral SCI. Following screening, eligible participants will enter 'Phase I', they will complete baseline outcome measures and then have the epidural spinal cord stimulator (eSCS) implanted with either percutaneous or paddle electrodes. Preoperative and intraoperative testing will determine exact location of electrodes.

Read full original descriptionShow less

Mapping and optimisation of stimulation parameters will be performed simultaneously with urodynamic investigations of bladder function, and anorectal physiology investigations of bowel function. The acute effects of eSCS to suppress bladder overactivity, facilitate voiding, prevent unwanted reflex sphincter activity, and pelvic floor function will guide development of eSCS programmes for use at home.

In 'Phase II', participants will use eSCS at home for 12-weeks. Participants will also be taught how to perform bladder and pelvic floor muscle training (PFMT) in combination with eSCS.

Outcome measures assessing bladder, bowel, sexual function, quality of life, motor function and spasticity will be captured prior to and following the 12-week intervention, and at 3 and 6 month follow up.

The group in the trial

  • TreatmentTreatment being tested

    Implantation of Epidural Spinal Cord Stimulation to target bladder and bowel function. Applied in combination with Pelvic Floor Muscle Training.

    Treatment: Epidural Spinal Cord Stimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury
Plain-language title
Spinal cord stimulation for bladder and bowel problems after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
14 March 2025